Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis
The cystic fibrosis (CF) transmembrane conductance regulator corrector/potentiator combinations lumacaftor/ivacaftor and elexacaftor/tezacaftor/ivacaftor improve sweat chloride, pulmonary function, and nutrition. Yet it is unclear whether they may also impact the progression of liver fibrosis, which...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2023-02-01
|
Series: | Hepatology Communications |
Online Access: | http://journals.lww.com/10.1097/HC9.0000000000000010 |